STM

Straumann

Stock
Stock
ISIN: CH1175448666
Ticker: STMN
CH1175448666
STMN

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Straumann has so far distributed $1.271 in 2026. The next dividend will be paid on 23.04.2027


$0.466

CHART BY

Frequently asked questions

The market capitalization of Straumann is $18.87B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Straumann is 42.19. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Straumann's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.804. EPS indicates the company's profitability on a per-share basis.
Currently, 21 analysts cover Straumann's stock, with a consensus target price of $140.17. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Straumann reported a revenue of $3.19B.
Straumann's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $865.47M. EBITDA measures the company's overall financial performance.
Straumann has a free cash flow of $463.10M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Straumann employs approximately 11,824 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Straumann is 113.52M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$18.87B
EPS (TTM) 
$2.804
Free Float 
113.52M
P/E ratio (TTM) 
42.19
Revenue (TTM) 
$3.19B
EBITDA (TTM) 
$865.47M
Free Cashflow (TTM) 
$463.10M

Pricing

1D span
$116.59$119.03
52W span
$92.87$135.74

Analyst Ratings

The price target is $140.17 and the stock is covered by 21 analysts.

Buy

14

Hold

6

Sell

1

Information

Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Western Europe, Sales Central Eastern Europe, Middle East and Africa (CEEMEA), Sales North America (NAM), Sales Asia Pacific (APAC), Sales Latin America (LATAM), and Operations. The Sales Western Europe segment comprises Group’s distribution businesses in Scandinavia, the UK, France, the Benelux countries, Iberia and Italy; implant-borne prosthetics business of Createch, as well as Anthogyr manufacturing plants, a French company that develops and manufactures dental implant systems and CADCAM solutions. The Sales CEEMEA segment comprises the Group's distribution businesses mainly in Germany, Switzerland, Austria, Hungary, the Czech Republic, Russia, Turkey, Croatia, Jordan and South Africa, as well as the business with European, African and Middle Eastern distributors. The Sales NAM segment comprises ClearCorrect’s clear-aligner business and its associated development and production activities. The Sales APAC segment comprises Group’s distribution businesses in the Asia pacific region, as well as the business with Asian distributors. The Sales LATAM segment comprises distribution and Instradent businesses in Middle and South America, and Latin America. The Operations segment manufactures plants, implants, and biomaterials. The company was founded by Reinhard Straumann in 1954 and is headquartered in Basel, Switzerland.

Employees
11,824
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
CH1175448666
Primary Ticker
STMN

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation